Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
AVAV
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
businesswire.com
9 hours ago
businesswire.com
9 hours ago
zacks.com
11 hours ago
marketbeat.com
11 hours ago
fool.com
16 hours ago
businesswire.com
17 hours ago
Earnings Growth
YoY
Current
Estimates
Q4.23
+462%
0.97
vs -0.27
Q1.24
+91%
0.63
vs 0.33
Q2.24
-57%
0.43
vs 0.99
Q3.24
-11%
0.89
vs 1
Q4.24
-52%
0.47
vs 0.97
Q1.25
-52%
0.3
vs 0.63
Q2.25
+274%
1.61
vs 0.43
Q3.25
-64%
0.32
vs 0.89
Q4.25
+56%
0.74
vs 0.47
Q1.26
+250%
1.05
vs 0.3
Sales Growth
YoY
Current
Estimates
Q4.23
+62%
180.8M vs 111.6M
Q1.24
+39%
186.6M vs 134.4M
Q2.24
+6%
197M vs 186M
Q3.24
+24%
189.5M vs 152.3M
Q4.24
+4%
188.5M vs 180.8M
Q1.25
-10%
167.6M vs 186.6M
Q2.25
+40%
275.1M vs 197M
Q3.25
+65%
313.5M vs 189.5M
Q4.25
+148%
467.9M vs 188.5M
Q1.26
+199%
500.4M vs 167.6M
Return on Equity
QoQ
Q2.23
-29%
-0.29
vs -0.00
Q3.23
+4%
0.04
vs -0.29
Q4.23
+2%
0.02
vs 0.04
Q1.24
+2%
0.02
vs 0.02
Q2.24
+1%
0.01
vs 0.02
Q3.24
+3%
0.03
vs 0.01
Q4.24
+1%
0.01
vs 0.03
Q1.25
0%
-0.00
vs 0.01
Q2.25
+2%
0.02
vs -0.00
Q3.25
-2%
-0.02
vs 0.02
Institutionnal Ownership
QoQ
Q1.23
273
273
vs 260
5%
Q2.23
285
285
vs 273
4%
Q3.23
314
314
vs 285
10%
Q4.23
338
338
vs 314
8%
Q1.24
387
387
vs 338
15%
Q2.24
432
432
vs 387
12%
Q3.24
444
444
vs 432
3%
Q4.24
436
436
vs 444
-2%
Q1.25
396
396
vs 436
-9%
Q2.25
514
514
vs 396
30%
Quote Panel
Key Metrics
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
262.50(-3.52%)
Number of analyst
2
Last analyst upgrade/downgrade
Citigroup
initialisePrevious: Not converted
2025-08-04
Now: Outperform
KeyBanc
initialisePrevious: Not converted
2025-06-29
Now: Overweight
Wedbush
upgradePrevious: Not converted
2025-06-25
Now: Outperform
Raymond James
downgradePrevious: Outperform
2024-09-16
Now: Market Perform
Relative Strength
AVAV
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|